Stockreport

INCY Wins EC Approval for Label Expansion of Oncology Drug Zynyz [Yahoo! Finance]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz (retifanlimab) for a second indication. The drug is [Read more]